JAMA Neurology · 2018 · 213 citations · 26 references
Population-based prevalence of amyloid-positive status and progression rates of amyloid positivity provide valid information for designing AD prevention trials and assessing the public health outcomes of AD prevention and interventions.
26
Clinical diagnosis of Alzheimer's disease
Guy M. McKhann, David A. Drachman, Marshall Folstein et al. · Neurology · 1984 · 27.8K citations · Full text
Guy M. McKhann, David S. Knopman, Howard Chertkow et al. · Alzheimer s & Dementia · 2011 · 18.4K citations · Full text
Marilyn S. Albert, Steven T. DeKosky, Dennis W. Dickson et al. · Alzheimer s & Dementia · 2011 · 9.9K citations
National Institute, Core Clinical Criteria, Diagnostic Guidelines +16
Reisa A. Sperling, Paul Aisen, Laurel Beckett et al. · Alzheimer s & Dementia · 2011 · 7K citations · Full text
Marilyn S. Albert, Steven T. DeKosky, Dennis W. Dickson et al. · FOCUS The Journal of Lifelong Learning in Psychiatry · 2013 · 2.6K citations